TY - JOUR AU - Ingelman-Sundberg, M. PY - 2005 DA - 2005// TI - The human genome project and novel aspects of cytochrome P450 research JO - Toxicol Appl Pharmacol VL - 207 UR - https://doi.org/10.1016/j.taap.2005.01.030 DO - 10.1016/j.taap.2005.01.030 ID - Ingelman-Sundberg2005 ER - TY - JOUR AU - Ingelman-Sundberg, M. AU - Rodriguez-Antona, C. PY - 2005 DA - 2005// TI - Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy JO - Philos Trans R Soc Lond B Biol Sci VL - 360 UR - https://doi.org/10.1098/rstb.2005.1685 DO - 10.1098/rstb.2005.1685 ID - Ingelman-Sundberg2005 ER - TY - JOUR AU - Sobrino, B. AU - Brión, M. AU - Carracedo, A. PY - 2005 DA - 2005// TI - SNPs in forensic genetics: a review on SNP typing methodologies JO - Forensic Sci Int VL - 154 UR - https://doi.org/10.1016/j.forsciint.2004.10.020 DO - 10.1016/j.forsciint.2004.10.020 ID - Sobrino2005 ER - TY - JOUR AU - Sobrino, B. AU - Carracedo, A. PY - 2005 DA - 2005// TI - SNP typing in forensic genetics: a review JO - Methods Mol Biol VL - 297 ID - Sobrino2005 ER - TY - JOUR AU - Crameri, A. AU - Marfurt, J. AU - Mugittu, K. AU - Maire, N. AU - Regös, A. AU - Coppee, J. AU - Sismeiro, O. AU - Burki, R. AU - Huber, E. AU - Laubscher, D. AU - Puijalon, O. AU - Genton, B. AU - Felger, I. AU - Beck, H. P. PY - 2007 DA - 2007// TI - Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs JO - J Clin Microbiol VL - 45 UR - https://doi.org/10.1128/JCM.01178-07 DO - 10.1128/JCM.01178-07 ID - Crameri2007 ER - TY - JOUR AU - Miller, J. AU - Trepanier, L. PY - 2002 DA - 2002// TI - Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation JO - Eur J Clin Pharmacol VL - 58 UR - https://doi.org/10.1007/s00228-002-0424-y DO - 10.1007/s00228-002-0424-y ID - Miller2002 ER - TY - JOUR AU - Li, X. AU - Björkman, A. AU - Andersson, T. AU - Ridderström, M. AU - Masimirembwa, C. PY - 2002 DA - 2002// TI - Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate JO - J Pharmacol Exp Ther VL - 300 UR - https://doi.org/10.1124/jpet.300.2.399 DO - 10.1124/jpet.300.2.399 ID - Li2002 ER - TY - JOUR AU - Khoo, S. AU - Back, D. AU - Winstanley, P. PY - 2005 DA - 2005// TI - The potential for interactions between antimalarial and antiretroviral drugs JO - AIDS VL - 19 UR - https://doi.org/10.1097/01.aids.0000174445.40379.e0 DO - 10.1097/01.aids.0000174445.40379.e0 ID - Khoo2005 ER - TY - JOUR AU - White, N. AU - van Vugt, M. AU - Ezzet, F. PY - 1999 DA - 1999// TI - Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine JO - Clin Pharmacokinet VL - 37 UR - https://doi.org/10.2165/00003088-199937020-00002 DO - 10.2165/00003088-199937020-00002 ID - White1999 ER - TY - JOUR AU - Svensson, U. AU - Ashton, M. PY - 1999 DA - 1999// TI - Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin JO - Br J Clin Pharmacol VL - 48 UR - https://doi.org/10.1046/j.1365-2125.1999.00044.x DO - 10.1046/j.1365-2125.1999.00044.x ID - Svensson1999 ER - TY - JOUR AU - Giao, P. AU - de Vries, P. PY - 2001 DA - 2001// TI - Pharmacokinetic interactions of antimalarial agents JO - Clin Pharmacokinet VL - 40 UR - https://doi.org/10.2165/00003088-200140050-00003 DO - 10.2165/00003088-200140050-00003 ID - Giao2001 ER - TY - JOUR AU - Li, X. AU - Björkman, A. AU - Andersson, T. AU - Gustafsson, L. AU - Masimirembwa, C. PY - 2003 DA - 2003// TI - Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data JO - Eur J Clin Pharmacol VL - 59 UR - https://doi.org/10.1007/s00228-003-0636-9 DO - 10.1007/s00228-003-0636-9 ID - Li2003 ER - TY - JOUR AU - Grace, J. AU - Aguilar, A. AU - Trotman, K. AU - Peggins, J. AU - Brewer, T. PY - 1998 DA - 1998// TI - Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450 JO - Drug Metab Dispos VL - 26 ID - Grace1998 ER - TY - JOUR AU - Projean, D. AU - Baune, B. AU - Farinotti, R. AU - Flinois, J. AU - Beaune, P. AU - Taburet, A. AU - Ducharme, J. PY - 2003 DA - 2003// TI - In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation JO - Drug Metab Dispos VL - 31 UR - https://doi.org/10.1124/dmd.31.6.748 DO - 10.1124/dmd.31.6.748 ID - Projean2003 ER - TY - JOUR AU - Kim, K. AU - Park, J. AU - Lee, J. AU - Lim, S. PY - 2003 DA - 2003// TI - Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes JO - Arch Pharm Res VL - 26 UR - https://doi.org/10.1007/BF02976712 DO - 10.1007/BF02976712 ID - Kim2003 ER - TY - JOUR AU - Halliday, R. AU - Jones, B. AU - Smith, D. AU - Kitteringham, N. AU - Park, B. PY - 1995 DA - 1995// TI - An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems JO - Br J Clin Pharmacol VL - 40 UR - https://doi.org/10.1111/j.1365-2125.1995.tb04559.x DO - 10.1111/j.1365-2125.1995.tb04559.x ID - Halliday1995 ER - TY - JOUR AU - Fontaine, F. AU - de Sousa, G. AU - Burcham, P. AU - Duchêne, P. AU - Rahmani, R. PY - 2000 DA - 2000// TI - Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes JO - Life Sci VL - 66 UR - https://doi.org/10.1016/S0024-3205(00)00546-4 DO - 10.1016/S0024-3205(00)00546-4 ID - Fontaine2000 ER - TY - JOUR AU - Ridtitid, W. AU - Wongnawa, M. AU - Mahatthanatrakul, W. AU - Raungsri, N. AU - Sunbhanich, M. PY - 2005 DA - 2005// TI - Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers JO - J Clin Pharm Ther VL - 30 UR - https://doi.org/10.1111/j.1365-2710.2005.00651.x DO - 10.1111/j.1365-2710.2005.00651.x ID - Ridtitid2005 ER - TY - JOUR AU - Ridtitid, W. AU - Wongnawa, M. AU - Mahatthanatrakul, W. AU - Chaipol, P. AU - Sunbhanich, M. PY - 2000 DA - 2000// TI - Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers JO - J Pharm Pharmacol VL - 52 UR - https://doi.org/10.1211/0022357001777243 DO - 10.1211/0022357001777243 ID - Ridtitid2000 ER - TY - JOUR AU - Kaneko, A. AU - Bergqvist, Y. AU - Taleo, G. AU - Kobayakawa, T. AU - Ishizaki, T. AU - Björkman, A. PY - 1999 DA - 1999// TI - Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations JO - Pharmacogenetics VL - 9 ID - Kaneko1999 ER - TY - JOUR AU - Skjelbo, E. AU - Mutabingwa, T. AU - Bygbjerg, I. AU - Nielsen, K. AU - Gram, L. AU - Brøosen, K. PY - 1996 DA - 1996// TI - Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians JO - Clin Pharmacol Ther VL - 59 UR - https://doi.org/10.1016/S0009-9236(96)80008-7 DO - 10.1016/S0009-9236(96)80008-7 ID - Skjelbo1996 ER - TY - JOUR AU - Mirghani, R. AU - Yasar, U. AU - Zheng, T. AU - Cook, J. AU - Gustafsson, L. AU - Tybring, G. AU - Ericsson, O. PY - 2002 DA - 2002// TI - Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway JO - Drug Metab Dispos VL - 30 UR - https://doi.org/10.1124/dmd.30.12.1368 DO - 10.1124/dmd.30.12.1368 ID - Mirghani2002 ER - TY - JOUR AU - Mirghani, R. AU - Hellgren, U. AU - Westerberg, P. AU - Ericsson, O. AU - Bertilsson, L. AU - Gustafsson, L. PY - 1999 DA - 1999// TI - The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo JO - Clin Pharmacol Ther VL - 66 UR - https://doi.org/10.1016/S0009-9236(99)70008-1 DO - 10.1016/S0009-9236(99)70008-1 ID - Mirghani1999 ER - TY - JOUR AU - Zhang, H. AU - Coville, P. AU - Walker, R. AU - Miners, J. AU - Birkett, D. AU - Wanwimolruk, S. PY - 1997 DA - 1997// TI - Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine JO - Br J Clin Pharmacol VL - 43 UR - https://doi.org/10.1046/j.1365-2125.1997.00556.x DO - 10.1046/j.1365-2125.1997.00556.x ID - Zhang1997 ER - TY - STD TI - Barraviera B, Pereira P, Machado J, de Souza M, Lima C, Curi P, Mendes R, Meira D: Isoniazid acetylating phenotype in patients with paracoccidioidomycosis and its relationship with serum sulfadoxin levels, glucose-6-phosphate dehydrogenase and glutathione reductase activities. Rev Soc Bras Med Trop. 24 (2): 111-114. ID - ref25 ER - TY - JOUR AU - Alfirevic, A. AU - Stalford, A. AU - Vilar, F. AU - Wilkins, E. AU - Park, B. AU - Pirmohamed, M. PY - 2003 DA - 2003// TI - Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity JO - Br J Clin Pharmacol VL - 55 UR - https://doi.org/10.1046/j.1365-2125.2003.01754.x DO - 10.1046/j.1365-2125.2003.01754.x ID - Alfirevic2003 ER - TY - JOUR AU - Daly, A. PY - 2004 DA - 2004// TI - Pharmacogenetics of the cytochromes P450 JO - Curr Top Med Chem VL - 4 UR - https://doi.org/10.2174/1568026043387070 DO - 10.2174/1568026043387070 ID - Daly2004 ER - TY - JOUR AU - Gil, J. PY - 2008 DA - 2008// TI - Amodiaquine pharmacogenetics JO - Pharmacogenomics VL - 9 UR - https://doi.org/10.2217/14622416.9.10.1385 DO - 10.2217/14622416.9.10.1385 ID - Gil2008 ER - TY - JOUR AU - Mehlotra, R. AU - Henry-Halldin, C. AU - Zimmerman, P. PY - 2009 DA - 2009// TI - Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy JO - Pharmacogenomics VL - 10 UR - https://doi.org/10.2217/14622416.10.3.435 DO - 10.2217/14622416.10.3.435 ID - Mehlotra2009 ER - TY - JOUR AU - Tarning, J. AU - Bergqvist, Y. AU - Day, N. AU - Bergquist, J. AU - Arvidsson, B. AU - White, N. AU - Ashton, M. AU - Lindegårdh, N. PY - 2006 DA - 2006// TI - Characterization of human urinary metabolites of the antimalarial piperaquine JO - Drug Metab Dispos VL - 34 UR - https://doi.org/10.1124/dmd.106.011494 DO - 10.1124/dmd.106.011494 ID - Tarning2006 ER - TY - JOUR AU - Klinker, H. AU - Langmann, P. AU - Richter, E. PY - 1996 DA - 1996// TI - Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS JO - Antimicrob Agents Chemother VL - 40 ID - Klinker1996 ER - TY - STD TI - Cavallito J, Nichol C, Brenckman WJ, Deangelis R, Stickney D, Simmons W, Sigel C: Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man. Drug Metab Dispos. 6 (3): 329-337. ID - ref32 ER - TY - JOUR AU - Lee, J. AU - Son, J. AU - Chung, S. AU - Lee, E. AU - Kim, D. PY - 2004 DA - 2004// TI - In vitro and in vivo metabolism of pyronaridine characterized by low-energy collision-induced dissociation mass spectrometry with electrospray ionization JO - J Mass Spectrom VL - 39 UR - https://doi.org/10.1002/jms.663 DO - 10.1002/jms.663 ID - Lee2004 ER - TY - JOUR AU - Rolan, P. AU - Mercer, A. AU - Tate, E. AU - Benjamin, I. AU - Posner, J. PY - 1997 DA - 1997// TI - Disposition of atovaquone in humans JO - Antimicrob Agents Chemother VL - 41 ID - Rolan1997 ER - TY - JOUR AU - Agwuh, K. AU - MacGowan, A. PY - 2006 DA - 2006// TI - Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines JO - J Antimicrob Chemother VL - 58 UR - https://doi.org/10.1093/jac/dkl224 DO - 10.1093/jac/dkl224 ID - Agwuh2006 ER - TY - JOUR AU - Kestler, H. PY - 2001 DA - 2001// TI - ROC with confidence - a Perl program for receiver operator characteristic curves JO - Comput Methods Programs Biomed VL - 64 UR - https://doi.org/10.1016/S0169-2607(00)00098-5 DO - 10.1016/S0169-2607(00)00098-5 ID - Kestler2001 ER - TY - JOUR AU - Landis, J. AU - Koch, G. PY - 1977 DA - 1977// TI - The measurement of observer agreement for categorical data JO - Biometrics VL - 33 UR - https://doi.org/10.2307/2529310 DO - 10.2307/2529310 ID - Landis1977 ER - TY - STD TI - Online Encyclopedia for Genetic Epidemiology studies. [http://www.oege.org/] UR - http://www.oege.org/ ID - ref38 ER - TY - JOUR AU - Thompson, W. AU - Walter, S. PY - 1988 DA - 1988// TI - A reappraisal of the kappa coefficient JO - J Clin Epidemiol VL - 41 UR - https://doi.org/10.1016/0895-4356(88)90031-5 DO - 10.1016/0895-4356(88)90031-5 ID - Thompson1988 ER - TY - JOUR AU - Vach, W. PY - 2005 DA - 2005// TI - The dependence of Cohen's kappa on the prevalence does not matter JO - J Clin Epidemiol VL - 58 UR - https://doi.org/10.1016/j.jclinepi.2004.02.021 DO - 10.1016/j.jclinepi.2004.02.021 ID - Vach2005 ER - TY - STD TI - Home Page of the Human Cytochrome P450 (CYP) Allele Nomenclature Committee. [http://www.cypalleles.ki.se/] UR - http://www.cypalleles.ki.se/ ID - ref41 ER - TY - JOUR AU - Lewis, D. AU - Watson, E. AU - Lake, B. PY - 1998 DA - 1998// TI - Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics JO - Mutat Res VL - 410 UR - https://doi.org/10.1016/S1383-5742(97)00040-9 DO - 10.1016/S1383-5742(97)00040-9 ID - Lewis1998 ER - TY - JOUR AU - Ibrahim, M. AU - Steenkeste, N. AU - Khim, N. AU - Adam, H. AU - Konaté, L. AU - Coppée, J. AU - Ariey, F. AU - Duchemin, J. PY - 2009 DA - 2009// TI - Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger JO - Malar J VL - 8 UR - https://doi.org/10.1186/1475-2875-8-32 DO - 10.1186/1475-2875-8-32 ID - Ibrahim2009 ER - TY - STD TI - Consensus Human Arylamine N-Acetyltransferase Gene Nomenclature. [http://louisville.edu/medschool/pharmacology/NAT.html] UR - http://louisville.edu/medschool/pharmacology/NAT.html ID - ref44 ER -